NO963331D0 - 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister - Google Patents

5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister

Info

Publication number
NO963331D0
NO963331D0 NO963331A NO963331A NO963331D0 NO 963331 D0 NO963331 D0 NO 963331D0 NO 963331 A NO963331 A NO 963331A NO 963331 A NO963331 A NO 963331A NO 963331 D0 NO963331 D0 NO 963331D0
Authority
NO
Norway
Prior art keywords
antagonists
receptor site
benzodiazepine receptor
site agonists
heteroarylindole
Prior art date
Application number
NO963331A
Other languages
English (en)
Other versions
NO963331L (no
Inventor
John E Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO963331D0 publication Critical patent/NO963331D0/no
Publication of NO963331L publication Critical patent/NO963331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO963331A 1994-02-10 1996-08-09 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister NO963331L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19455394A 1994-02-10 1994-02-10
PCT/IB1994/000407 WO1995021836A1 (en) 1994-02-10 1994-12-08 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists

Publications (2)

Publication Number Publication Date
NO963331D0 true NO963331D0 (no) 1996-08-09
NO963331L NO963331L (no) 1996-10-09

Family

ID=22718035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963331A NO963331L (no) 1994-02-10 1996-08-09 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister

Country Status (12)

Country Link
US (1) US5688809A (no)
EP (1) EP0743942A1 (no)
JP (1) JP2829788B2 (no)
KR (1) KR970701182A (no)
CN (1) CN1067386C (no)
AU (1) AU685881B2 (no)
CA (1) CA2183084A1 (no)
FI (1) FI950568A (no)
IL (1) IL112519A0 (no)
NO (1) NO963331L (no)
NZ (1) NZ276172A (no)
WO (1) WO1995021836A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980375A2 (en) 1997-07-03 1999-04-30 Argyrios Georgios Arvanitis Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US7442709B2 (en) * 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
RU2006108791A (ru) 2003-08-21 2006-07-27 Оси Фармасьютикалз, Инк. (Us) N-замещенные пиразолиламидилбензимидазолилы в качестве с-kit ингибиторов
EP1664021A1 (en) * 2003-08-21 2006-06-07 OSI Pharmaceuticals, Inc. N-substituted benzimidazolyl c-kit inhibitors
JP2008521903A (ja) * 2004-12-01 2008-06-26 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド Ｎ置換されたベンズイミダゾリルＣ−ｋｉｔ阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
AU2016255424B2 (en) 2015-04-29 2020-10-08 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
AU2016255434C1 (en) * 2015-04-29 2021-09-23 Rapport Therapeutics, Inc. Azabenzimidazoles and their use as AMPA receptor modulators
CA2984305C (en) 2015-04-29 2021-12-28 Janssen Pharmaceutica Nv Indolone compounds and their use as ampa receptor modulators
WO2016176457A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
KR101831553B1 (ko) 2017-01-23 2018-02-22 계명대학교 산학협력단 전이성 유방암의 유용한 신규 화합물 및 이의 의학적 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066654A (en) * 1990-10-22 1991-11-19 A. H. Robins Company, Incorporated 2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
TW251284B (no) * 1992-11-02 1995-07-11 Pfizer

Also Published As

Publication number Publication date
NO963331L (no) 1996-10-09
US5688809A (en) 1997-11-18
CA2183084A1 (en) 1995-08-17
JP2829788B2 (ja) 1998-12-02
FI950568A (fi) 1995-08-11
FI950568A0 (fi) 1995-02-09
JPH09501949A (ja) 1997-02-25
EP0743942A1 (en) 1996-11-27
AU685881B2 (en) 1998-01-29
WO1995021836A1 (en) 1995-08-17
AU1033995A (en) 1995-08-29
IL112519A0 (en) 1995-05-26
CN1142823A (zh) 1997-02-12
NZ276172A (en) 1998-02-26
CN1067386C (zh) 2001-06-20
KR970701182A (ko) 1997-03-17

Similar Documents

Publication Publication Date Title
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DK1035115T3 (da) 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
DK1086086T3 (da) Imidazolylderivater og anvendelse deraf som somatostatinreceptorligander
DK0832061T3 (da) Benzamidderivater og anvendelse deraf som vasopressin-antagonister
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
ATE315035T1 (de) Ccr-3-rezeptor-antagonisten
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
ID16742A (id) Antagonis reseptor endotelin
NO995482D0 (no) Ergolinderivater og deres anvendelse som somatostatinreseptorantagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
NO950606D0 (no) Adhesjonsreseptor-antagonister
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DE69506826D1 (de) 5-HT4 Rezeptoragonisten
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
NO990786D0 (no) Acylaminoalkenylen-amidderivater som NK1 og NK2 antagonister
NO970372D0 (no) Aroyloksy- og aroyltiopropanolamin-derivater anvendelige som <beta>-3-adrenoreseptor-agonister og antagonister for <beta>-1-og-<beta>-2-adrenoreseptorer og farmasöytiske blandinger derav
NO985970L (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO985621D0 (no) FremgangsmÕte og system for boring under anvendelse av skum - skumsammensetning
NO985972D0 (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
NO992976D0 (no) Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister